KORU Medical Systems (NASDAQ:KRMD) Price Target Raised to $5.00

KORU Medical Systems (NASDAQ:KRMD) had its price objective hoisted by Craig Hallum from $4.00 to $5.00 in a research note published on Thursday,Benzinga reports. The firm currently has a buy rating on the stock.

A number of other equities research analysts also recently commented on the company. Piper Sandler upped their price objective on KORU Medical Systems from $3.00 to $3.50 and gave the company an “overweight” rating in a report on Thursday. Canaccord Genuity Group upped their price objective on KORU Medical Systems from $3.00 to $4.00 and gave the company a “buy” rating in a report on Thursday. Finally, B. Riley assumed coverage on KORU Medical Systems in a report on Thursday, July 25th. They issued a “buy” rating and a $4.00 price target for the company.

KORU Medical Systems Trading Up 2.9 %

NASDAQ KRMD opened at $3.17 on Thursday. The stock has a 50-day simple moving average of $2.67 and a 200 day simple moving average of $2.48. The company has a market capitalization of $145.31 million, a PE ratio of -12.68 and a beta of 0.41. The company has a current ratio of 2.99, a quick ratio of 3.27 and a debt-to-equity ratio of 0.01. KORU Medical Systems has a 12 month low of $1.98 and a 12 month high of $3.40.

Institutional Investors Weigh In On KORU Medical Systems

Large investors have recently modified their holdings of the business. Aaron Wealth Advisors LLC bought a new stake in shares of KORU Medical Systems in the second quarter worth about $28,000. Allspring Global Investments Holdings LLC bought a new position in shares of KORU Medical Systems during the second quarter worth about $28,000. XTX Topco Ltd bought a new position in shares of KORU Medical Systems during the third quarter worth about $34,000. Legato Capital Management LLC bought a new position in shares of KORU Medical Systems during the second quarter worth about $35,000. Finally, Virtu Financial LLC bought a new position in shares of KORU Medical Systems during the first quarter worth about $63,000. 58.60% of the stock is currently owned by institutional investors.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.